300239.SZ
东宝生物
SZSE · Healthcare · C 制造业 · CN
CNY 4.98
−5.50%Margins
Gross margin
23.2%
EBITDA margin
21.1%
EBIT margin
8.0%
Net margin
7.4%
FCF margin
6.3%
3.2%
Return on equity
2.1%
Return on assets
3.4%
Return on invested capital
0.29x
Asset turnover
CNY 164.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026